Intellia Therapeutics shares owned by Capital Impact Advisors
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Capital Impact Advisors
from 13F filings
Historical chart of Capital Impact Advisors investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Capital Impact Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $594k | 27k | 22.38 |
| 2024-03-31 | $880k | 32k | 27.51 |
| 2023-12-31 | $797k | 26k | 30.49 |
| 2023-09-30 | $360k | 11k | 31.62 |
| 2023-06-30 | $464k | 11k | 40.78 |
| 2023-03-31 | $399k | 11k | 37.27 |
| 2022-12-31 | $374k | 11k | 34.89 |
| 2022-09-30 | $586k | 12k | 49.02 |
| 2022-06-30 | $595k | 12k | 51.78 |
| 2022-03-31 | $596k | 8.2k | 72.68 |
| 2021-12-31 | $575k | 4.9k | 118.26 |
| 2021-09-30 | $1.0M | 7.5k | 134.13 |
| 2021-03-31 | $359k | 4.5k | 80.35 |
| 2020-12-31 | $12M | 220k | 54.40 |
| 2020-09-30 | $2.2M | 110k | 19.88 |
More positions owned by Capital Impact Advisors
View all positions for Capital Impact Advisors